Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895213 · ClinicalTrials.gov registry record
Evaluation of Plasma Renin Concentrations in Cardiac Surgery
A clinical trial of Cardiac Surgery With Cardiopulmonary Bypass, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06895213 is a study of Cardiac Surgery With Cardiopulmonary Bypass that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06895213, a study of Cardiac Surgery With Cardiopulmonary Bypass, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to learn more about how renin (a blood test) is affected by cardiopulmonary bypass, the heart-lung machine used during open heart surgery. Renin is a protein that may be elevated in response to low blood pressure or situations where organs do not receive sufficient oxygen. Renin may potentially be used as an indicator for specific treatments aimed to increase the blood pressure. This study will evaluate blood samples for renin concentration throughout the course of open heart surgery.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-04-14 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06895213
The ClinicalTrials.gov registry entry for NCT06895213 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Surgery With Cardiopulmonary Bypass appearing as the primary indexed condition, and to 0 interventions.
NCT06895213 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06895213 about?
NCT06895213 is a clinical study titled "Evaluation of Plasma Renin Concentrations in Cardiac Surgery". The purpose of this research is to learn more about how renin (a blood test) is affected by cardiopulmonary bypass, the heart-lung machine used during open heart surgery. Renin is a protein that may be elevated in response to low blood pressure or situations where organs do not receive sufficient ox...
What is the current status of trial NCT06895213?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-04-14. Estimated completion is 2026-05.
What conditions does trial NCT06895213 study?
This clinical trial studies the following conditions: Cardiac Surgery With Cardiopulmonary Bypass.
Who is sponsoring clinical trial NCT06895213?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06895213 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.